series-a
Stage
2022
Founded
1
Investors
About
Operator of a medical research company intended to treat patients suffering from refractory epilepsy. The company's patented technology is used for effective diagnosis and treatment, providing patients with a chance to fight against epilepsy.
Explore NxNeuro's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.